tykhr
sign in
free sign up
Genelux Corporation Common Stock
Biotechnology
Healthcare
GNLX
34.93 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
4.19
52 week high
5.66
high
4.50
52 week low
0.00
low
4.13
growth
95.50 %
previous Close
4.11
P/E ratio
market cap
133 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
1657.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top